Hear from 23+ industry experts to help you:

• Take your stem cell therapy from concept to clinic with industry and regulatory talks – keynotes from Michael Hunt of ReNeuron and the European Medicines Agency (EMA) Committee for Advanced Therapies (CAT)
• Understand and gain an advantage from the benefits and limitations of cell vs drug therapy; insights from Yen Choo, Progenitor Labs (part of Plasticell)
• Enhance project decision making by having information-rich stem cell assays earlier in the pipeline; discussion led by Rachel Russel of Pfizer
• Accelerate your drug discovery and development and ultimately reduce development cost with a top-down strategic assessment of early discovery drug safety; expert take-home messages from the Drug Safety Executive Council (DSEC) interactive panel discussion
• Boost predictive toxicology accuracy and reduce late stage drug attrition by capitalising on new technology and techniques including incorporating stem cell models and high content analysis. Exclusive presentations from Pfizer, AstraZeneca and GSK

Remember, your pass also includes access to the co-located 4th Annual Predictive Toxicology Summit 2012, which shares some keynote and plenary presentations.

We look forward to meeting you in London!

What People Have Said about the Predictive Toxicology Summit

“Overall very valuable, learning about new technology & forming partnerships to move the industry forward”

“An excellent, informative conference as a refresher for current standing in predictive tox”

“Highly valuable and useful”